Wilson Sonsini Goodrich & Rosati is pleased to support LaunchBio’s Larger Than Life Science: Prospective Therapies. Market Challenges, Cutting Edge Medicinal Products.  Drug development has cutting edge innovations like cell and gene therapies addressing previously unmet needs including genetic disorders and critical disease indications in oncology, autoimmune disease, etc. With these new medicinal technologies, challenges arise with characterizing these new medicines, assessing potential toxicities and uncertain regulatory hurdles to bring them to patients.  This session will review creating and using relevant animal models, developing regulatory safety strategies towards human clinical trials, sharing experiences in navigating novel drug development programs and the future evolution of advanced therapy development.